PerMedCoE combines clinical patient data with data related to the operation of genes, proteins and cells. The goal is to develop easy-to-use tools that can be used in precision medicine, leveraging the power of modern supercomputers.
Recently a feature on the Horizon 2020 PerMedCoE project, titled Personalised medicine against cancer and viruses, was published on the ELIXIR Finland website.
The text features commentaries from CSC - IT Center for Science (Project Manager Sampo Sillanpää and myself), as well as the Institute for Molecular Medicine Finland (Group Leader Esa Pitkänen).